A pharmaceutical for use in the treatment of Perkinson's disease which comprises a vector having a mediatophore-encoding gene integrated therein and which can express mediatophore in the brain.
PHARMACEUTICAL FOR TREATMENT OF PARKINSON'S DISEASE